Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 and up

Assessing the safety of EO2002 after cataract surgery

Official title: Phase 1, Randomized, Masked, Sham-Controlled Study to Assess the Safety and Tolerability of EO2002 in Subjects Undergoing Cataract Surgery

Run by Asociación para Evitar la Ceguera en México · NCT05587205 · Data updated 2026-11-12

This study is testing if a new treatment called EO2002 is safe for people who have just had cataract surgery.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorAsociación para Evitar la Ceguera en México
Academic / other
Locations1 site (Mexico City, Mexico City)
StatusRecruiting
StartedAugust 30, 2022
Main results expectedOctober 6, 2026
Study endsOctober 6, 2026
Registry record updatedDecember 8, 2025
Trial IDNCT05587205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a history of uncomplicated cataracts requiring surgery and decreased endothelial cell counts.

Probably not a fit

Patients with other corneal diseases, significant macular disease, or recent ocular surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study evaluates the safety and tolerability of EO2002, administered through an intracameral injection, in patients who have undergone cataract surgery. The trial focuses on individuals with a history of uncomplicated cataracts and decreased endothelial cell counts. Participants will receive either the EO2002 treatment or a sham injection to compare outcomes. The study aims to gather data on the safety profile of EO2002 in this specific patient population.

Why it matters

Potential benefit: If successful, this treatment could improve recovery and outcomes for patients undergoing cataract surgery.

How similar studies have gone: While this approach is novel in the context of EO2002, similar studies assessing safety in ocular treatments have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

1. Age ≥ 18 years.
2. Subject has uncomplicated history of cataract that has progressed to a level requiring standard cataract extraction with intraocular lens implant surgery.
3. Decreased endothelial cell count

Exclusion Criteria:

All ocular criteria apply to study eye unless otherwise noted.

1. Other corneal disease
2. Macular disease that in the investigator and/or sponsor's opinion would limit the ability of the subject to demonstrate improvement in BCVA.
3. Descemet membrane detachment.
4. History of uveitis or other ocular inflammatory disease.
5. History of incisional glaucoma surgery
6. Prior incisional eye surgery within 3 months prior to study treatment or penetrating or endothelial keratoplasty.
7. History of ocular neoplasm.
8. ETDRS BCVA in the fellow eye is worse than 35 letters (Snellen equivalent of 20/200).
9. Female who is pregnant, nursing, or planning to become pregnant, or who is of childbearing potential and not using a reliable means of contraception during the study.
10. Subject is currently participating in or has participated within the last 3 months in any other clinical trial of an investigational drug by ocular or systemic administration.
11. Any concomitant medical or psychological condition that could interfere with study participation or is otherwise not suitable for entry into the study in the opinion of the investigator.

Where it's running

  • Asociacion para Evitar la Ceguera en Mexico
    Mexico City, Mexico City, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.